financetom
Business
financetom
/
Business
/
Vertex Q1 Non-GAAP Earnings, Revenue Rise; Issues Q2, 2024 Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertex Q1 Non-GAAP Earnings, Revenue Rise; Issues Q2, 2024 Revenue Guidance
May 8, 2024 5:50 AM

08:14 AM EDT, 05/08/2024 (MT Newswires) -- Vertex (VERX) reported Q1 non-GAAP earnings Wednesday of $0.15 per diluted share, up from $0.08 a year earlier.

Analysts polled by Capital IQ expected $0.13.

Revenue for the quarter ended March 31 was $156.8 million, up from $132.8 million a year earlier.

Analysts surveyed by Capital IQ expected $155.2 million.

The tax compliance software provider said it expects Q2 revenue of $159 million to $162 million. Analysts polled by Capital IQ expect $160.6 million.

For full-year 2024, the company said it expects revenue of $650 million to $660 million. Analysts polled by Capital IQ expect $657 million.

Shares of Vertex were 2.7% higher in recent Wednesday premarket activity.

Price: 30.96, Change: +0.81, Percent Change: +2.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pinnacle Financial Partners Insider Sold Shares Worth $383,114, According to a Recent SEC Filing
Pinnacle Financial Partners Insider Sold Shares Worth $383,114, According to a Recent SEC Filing
Dec 10, 2024
04:05 PM EST, 12/10/2024 (MT Newswires) -- Harold R Carpenter, Executive Vice President & CFO, on December 09, 2024, sold 3,051 shares in Pinnacle Financial Partners ( PNFP ) for $383,114. Following the Form 4 filing with the SEC, Carpenter has control over a total of 74,164 shares of the company, with 60,805 shares held directly and 13,359 controlled indirectly....
Theratechnologies Gets US FDA's Target Action Date for F8 Formulation of Tesamorelin
Theratechnologies Gets US FDA's Target Action Date for F8 Formulation of Tesamorelin
Dec 10, 2024
04:06 PM EST, 12/10/2024 (MT Newswires) -- Theratechnologies ( THTX ) said Tuesday that the US Food and Drug Administration assigned a Prescription Drug User Fee Act goal date of March 25 for the supplemental biologics license application for F8 formulation of tesamorelin. The company said it plans to replace the F4 formulation, or Egrifta SV, with the F8 formulation...
Biden plans to block Nippon Steel purchase of US Steel, Bloomberg News reports
Biden plans to block Nippon Steel purchase of US Steel, Bloomberg News reports
Dec 10, 2024
(Reuters) -U.S. President Joe Biden plans to formally block Nippon Steel's proposed takeover of U.S. Steel on national security grounds once the $15 billion deal is referred back to him later this month, Bloomberg News reported on Tuesday, citing people familiar with the matter. Asked about Biden's plans on the deal, which is being reviewed by a national security panel,...
Pinnacle Financial Partners Insider Sold Shares Worth $617,368, According to a Recent SEC Filing
Pinnacle Financial Partners Insider Sold Shares Worth $617,368, According to a Recent SEC Filing
Dec 10, 2024
03:58 PM EST, 12/10/2024 (MT Newswires) -- Richard D Callicutt II, Director, Chairman, Carolinas & Virginia, on December 06, 2024, sold 4,913 shares in Pinnacle Financial Partners ( PNFP ) for $617,368. Following the Form 4 filing with the SEC, Callicutt has control over a total of 95,303 shares of the company, with 95,303 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1115055/000111505524000188/xslF345X05/wk-form4_1733863858.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved